Pfizer tests painless blood draws for migraine drug

This study tested new, less invasive devices for collecting blood samples at home compared to standard needle draws in a clinic. Fourteen healthy adults received a single dose of a nasal spray migraine medication (zavegepant). Researchers compared blood levels of the drug measured from the new devices to those from traditional blood draws to see if they gave similar results. The study also looked at the taste of the nasal spray and whether a candy could improve it.